Biora Therapeutics Company Description
Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States.
The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases.
The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline.
Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California. On December 27, 2024, Biora Therapeutics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
| Country | United States |
| Founded | 2010 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 58 |
| CEO | Aditya Mohanty |
Contact Details
Address: 4330 La Jolla Village Drive San Diego, Delaware 92122 United States | |
| Phone | 833 727 2841 |
| Website | bioratherapeutics.com |
Stock Details
| Ticker Symbol | BIORQ |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Aditya Mohanty | Chief Executive Officer |
| Eric d'Esparbes | Chief Financial Officer |